Medicus Pharma Ltd. Common Stock
MDCX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $0 | $1 | $1 |
| G&A Expenses | $0 | $2 | $0 | $0 |
| SG&A Expenses | $8 | $2 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2 | $0 | $0 |
| Operating Expenses | $11 | $5 | $1 | $1 |
| Operating Income | -$11 | -$5 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$11 | -$5 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$5 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS | -1.1 | -1.53 | -0.88 | -0.26 |
| % Growth | 28.1% | -73.9% | -238.5% | – |
| EPS Diluted | -1.1 | -1.53 | -0.21 | -0.26 |
| Weighted Avg Shares Out | 10 | 3 | 2 | 8 |
| Weighted Avg Shares Out Dil | 10 | 3 | 8 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | -$1 | -$1 |
| Interest Expense | $0 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $2 | $0 | $0 |
| EBITDA | -$11 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |